Stocks · News reference
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Keybanc analyst Zach Haggerty initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Overweight rating and announces Price Target of $52.
Truist Securities analyst David Macdonald maintains Guardian Pharmacy Service (NYSE:GRDN) with a Buy and raises the price target from $47 to $51.
BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.
Pediatrix Medical Group (MD) reported 4% YoY revenue growth to $487.8 million in Q2 2026, driven by improved reimbursement and higher patient acuity, offsetting a 2.1% decline in patient volumes. The company reaffirmed its 2026 adjusted EBITDA guidance of $280-$300 million, though volume trends and easing collection benefits remain key risks.
MRVL stock falls in tech pullback, but analysts see huge AI opportunity ahead. Explore key targets and technicals.